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ABSTRACT: 
BACKGROUND:  
Between December 2013 and June 2016, West Africa experienced the largest Ebola virus disease 
(EVD) outbreak in history. Understanding EVD in pregnancy is important for EVD clinical screening 
and infection prevention and control.  
METHODS:  
We conducted a review of medical records and EVD investigation reports from three districts in 
Sierra Leone. We report the clinical presentations and maternal and fetal outcomes of six pregnant 
women with atypical EVD, and subsequent transmission events from perinatal care. 
RESULTS:  
The six women (ages 18 – 38) were all in the third trimester. Each presented with signs and 
symptoms initially attributed to pregnancy. None met EVD case definition; only one was known at 
presentation to be a contact of an EVD case. Five women died, and all six fetuses/neonates died. 
These cases resulted in at least 35 additional EVD cases.  
CONCLUSIONS:  
These cases add to the sparse literature focusing on pregnant women with EVD, highlighting 
challenges and implications for outbreak control. Infected newborns may also present atypically and 
may shed virus while apparently asymptomatic. Pregnant women identified a priori as contacts of 
EVD cases require special attention and planning for obstetrical care.  
KEYWORDS: 
Ebola; Pregnancy; Sierra Leone; Outbreak; Epidemic 
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BACKGROUND 
Between December 2013 and June 2016, West Africa experienced the largest outbreak of Ebola virus 
disease (EVD) in history, with at least 28,646 cases and 11,323 deaths.1 Prior to this outbreak, the 
small number (2,345) of cumulative cases of EVD meant that relatively little was known about the 
clinical course of EVD,2 especially in pregnant women. Few reports describe the clinical outcomes in 
pregnant women infected with EVD, and their newborns.3-17 Previous reports largely described 
pregnant women with EVD who presented with typical symptoms, spontaneous abortion,4-6,8,12-14,18-20 
pregnancy-related hemorrhage,6,7,9,12-14,,20 and stillbirth.6,7,12-14,16,18 While mortality has historically 
been very high among pregnant women with EVD (averaging 86% in a review by Bebell et al. of 111 
patients),21 there are increasing reports of maternal survival, usually but not universally 
accompanied by fetal loss.4-14,16,17 We are aware of four previous reports each involving a single 
pregnant woman with EVD who presented in labour without fever or typical symptoms of EVD.22-25 
Understanding EVD in pregnancy is important for clinical EVD screening. Symptoms associated with 
pregnancy and labour can mimic EVD.26 EVD in pregnancy is also important for infection prevention 
and control (IPC) because in addition to transplacental EVD transmission, fetal and horizontal 
transmission (for example, to birth attendants) can occur via contact with Ebola virus (EBOV) in the 
products of conception, such as amniotic fluid and the placenta.6,16,18,27  EBOV testing from some 
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cases suggests that the amniotic fluid remains a reservoir for Ebola virus persistence even after 
maternal symptoms resolve and the virus is no longer detectable in peripheral blood.18,27 
In May 2015, several districts in Sierra Leone began to systematically collect data on pregnancy 
among all patients with EVD. We observed atypical clinical presentations of EVD among several of 
the pregnant women. Here we report the clinical presentations and the maternal and fetal outcomes 
of six pregnant women in Sierra Leone who did not meet the World Health Organization (WHO) EVD 
case definition in use at the time,n and the secondary transmission events from obstetric and/or 
neonatal care. We discuss the urgent implications of these findings on clinical and public health 
practice in EVD outbreaks. 
 
METHODS 
We reviewed all available medical records from health facilities that treated patients with EVD in 
three of the most EVD-affected districts of Sierra Leone: Makeni General Hospital in Bombali district; 
Maforki Ebola Treatment Centre (ETC) and the International Medical Corps ETC in Port Loko district; 
and Princess Christian Maternity Hospital and Aberdeen Women’s Centre, in Freetown. We also 
reviewed all EVD case investigation reports from the same districts. We selected all records for 
women with EVD who were reported as pregnant and who did not meet the EVD case definition. Six 
                                                          
n
 The official definition of a suspect case was unexplained bleeding or miscarriage; OR, unexplained death; OR, 
fever (≥38·0
o 
C) and three or more of the symptoms/signs of headache, abdominal pain, generalized or 
articular pain, difficulty in swallowing, intense fatigue, difficulty in breathing, nausea or vomiting, hiccups, loss 
of appetite, miscarriage, or diarrhoea; OR, fever and contact with a clinical (suspect, probable or confirmed) 
EVD case; OR, three or more symptoms and contact with a clinical case.
28
 A probable case, while not officially 
defined, was most commonly either a suspect case that was known to have had contact with a clinical case; 
OR, a patient that was, on clinical and/or epidemiological grounds, very likely to have EVD.  
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such records were identified, and their relevant clinical and epidemiologic characteristics were 
summarized in a case series. 
The proportion of pregnant women who did not meet the EVD case definition was not calculated 
because the total number of EVD-affected pregnant women (i.e. the denominator) was unavailable 
due to inconsistent reporting of pregnancy status, particularly in records prior to May 2015.  
ETHICAL APPROVAL 
Approval for this study was obtained from the Sierra Leone Ethics and Scientific Review Committee. 
As the study involved retrospective review of records, no individual patient consent was obtained.  
 
CASE SERIES 
Case 1 
Initial presentation and clinical course  
In November 2014, a 25-year-old female in the third trimester of pregnancy presented to Makeni 
General Hospital in Bombali district with abdominal pain consistent with labour. She had no other 
symptoms, was afebrile, had normal conjunctivae, and appeared well. At the time of admission, 
systematic EVD screening was not in place at the facility and she was not questioned about potential 
EVD exposures. Two hours after admission, the neonate was delivered by uncomplicated 
spontaneous vaginal delivery. The neonate appeared healthy and was feeding well. The nurse who 
performed the delivery wore routine obstetrical personal protective equipment (PPE) including a 
disposable gown and gloves. 
Unexpectedly, 12 hours later, the patient developed profuse vaginal bleeding and required a blood 
transfusion. Despite administration of ergometrine and oxytocin, the vaginal bleeding persisted and 
she began bleeding at the site of the peripheral intravenous cannula. Although she remained 
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afebrile, the bleeding alerted medical staff to the possibility of EVD. She was moved to an EVD 
isolation ward attached to the hospital pending transfer to a facility for patients suspected of EVD. 
However, she continued to bleed and died of post-partum hemorrhage several hours later. As per 
standard practice for all deaths during this time, post-mortem reverse transcriptase polymerase 
chain reaction (RT-PCR) testing was performed on an oral swab and found to be positive for EBOVo. 
The neonate was never tested for EBOV and was discharged home to the care of family members in 
the father’s village, as there was no suspicion of EVD. The products of conception (amniotic fluid, 
placenta) were not tested for EBOV.  
EBOV exposure 
Subsequent epidemiologic investigation uncovered that the patient was from a quarantined village 
and had been identified as a possible contact of a known case of EVD within the 21 days prior to 
admission. When labour began, she broke her quarantine, travelled to the hospital, and used her 
husband's address from a different village because of fear that she would otherwise be denied 
health care.  
Secondary cases  
None of the healthcare staff involved in the delivery developed EVD. However, contact 
investigations revealed that another pregnant woman who delivered a neonate at the same time 
and in the same delivery room, and was cared for by the same health-care providers, died of EVD 
twelve days post-partum and was likely infected through nosocomial transmission. 
The baby became ill and died soon after discharge. Direct child-care and a traditional burial of the 
baby triggered an outbreak of an unknown number of additional EVD cases in the case patient’s 
husband’s village. 
                                                          
o
 RT-PCR cycling times were not recorded in medical records for any of the six patients described. 
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Case 2 
Initial presentation and clinical course 
In December 2014, an 18-year-old pregnant female presented to the Maforki Ebola Treatment 
Centre (ETC) in Port Loko district, almost at full term and in the initial stages of labour. She was 
afebrile, but was experiencing abdominal pain, vomiting, muscle pain, headache and diarrhoea. She 
denied a history of known EVD exposure; thus, lacking either fever or EVD exposure, she did not 
meet the case definition despite having multiple other symptoms of EVD. She was transferred to the 
Princess Christian Maternity Hospital (PCMH)’s EVD isolation unit in Freetown for higher-level 
obstetrical care and because of a clinical suspicion of EVD despite not meeting the case definition. 
EBOV RT-PCR testing on admission was positive. At the hospital, she became febrile (39°C) and 
delivered via spontaneous vaginal delivery, assisted by health-care providers in full PPE. She 
developed severe post-partum hemorrhage and hypovolemic shock, and died on the day of 
admission. The products of conception were not tested for EVD.  
The healthy newborn was transferred to the Port Loko Observational Interim Care Centre (an 
observation Centre for asymptomatic children of EVD-infected parents or guardians). On day 15 of 
life, the neonate became unwell and was isolated to the suspect ward of the Maforki Ebola 
Treatment Centre (ETC). Blood tests were positive for EBOV by RT-PCR. The neonate died on day 19.  
EBOV exposure 
The source of the mother’s infection could not be determined. 
Secondary cases 
None detected.  
Case 3 
Initial presentation and clinical course 
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In January 2015, a 35-year-old female in her third trimester of pregnancy went into labour while 
quarantined at her home in Kambia district as a contact of an EVD case. The patient was brought by 
ambulance to a local Holding Centre (a facility used for holding suspect cases pending their 
laboratory result), out of precaution because she was a contact, not out of suspicion of EVD. She 
tested negative for EBOV. She was transferred to PCMH’s isolation unit in Freetown, where she 
again tested negative and subsequently delivered a healthy neonate. The delivery was assisted by 
health-care providers in full PPE. The patient was discharged and immediately returned to Kambia to 
a neighbouring village, as her home was still under quarantine. The products of conception were not 
tested for EVD. 
Within a few days of discharge, she developed a fever. On route to hospital, her motorbike was 
involved an accident and she died at the scene. A post-mortem oral swab was positive for EBOV. 
Two days later, the neonate fell ill and with conjunctivitis and fever. The neonate was returned to 
Princess Christian Maternity Hospital in Freetown and died shortly after admission. A post-mortem 
swab of the neonate was EBOV-positive.  
EBOV exposure 
Patient was a known contact in a quarantined home.  
Secondary cases  
Investigation revealed that no attending healthcare developed EVD. However, a family member who 
may have cared for the patient and the neonate post-partum was infected. The family member’s 
infection triggered a transmission chain of 23 onward cases.  
Case 4  
Initial presentation and clinical course 
Jo
urn
al 
Pre
-pr
oo
f
9 
 
In February 2015, a 38-year-old female in Port Loko district delivered a healthy neonate at home at 
36 weeks gestation. She reported no symptoms other than labour pains prior to delivery; this was 
later corroborated by family members. The delivery was complicated by post-partum hemorrhage 
the following day, and the patient died approximately four hours later. The delivery and post-partum 
care was assisted by two women at home. No gloves or other PPE were used during the delivery, 
post-partum care, discarding of tissues, washing of the neonate, or cleaning of the delivery area 
(linens).  The remaining products of conception were reportedly discarded in the latrine, including 
the placenta, which was not discoloured and appeared healthy. A post-mortem oral swab was 
positive for EBOV, and reported to the Ebola surveillance team when the newborn was 3 days old.  
The newborn was described as feeding well and showing no symptoms of EVD. However, the Ebola 
response team felt that the newborn was likely to have been infected during gestation or childbirth. 
Thus, the newborn was taken to the International Medical Corps ETC, and into a single ward (with no 
other patients), as a precautionary measure to enable early EVD detection/diagnosis and interrupt 
onward transmission. This ETC was chosen because of the availability of nearly 24-hour care by EVD 
survivors wearing light PPE (disposable gowns and gloves). The EVD survivor care enabled near-
constant hands-on supportive and nutritional care, in addition to the clinical care provided by the 
other staff in full PPE.  
Admission blood tests, on day 4 of life, were RT-PCR-negative for EBOV. A repeat blood RT-PCR on 
day 6 of life was positive. Throughout this time, the newborn still appeared well, was feeding fell 
with wet diapers, and had no detectable signs of EVD. At seven days of age, the neonate suddenly 
became unwell, developed a fever, and died on the following day.  
EBOV exposure 
Subsequent epidemiologic investigation found that 10 to 12 days prior to delivery, the pregnant 
patient had been visiting the quarantined home of her step-mother while the step-mother was 
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symptomatic with EVD. Thus, the pregnant patient was a contact of a known EVD case, but the 
exposure was only discovered after the post-mortem EVD diagnosis. 
Secondary cases  
One woman who assisted in the birth, as well as her son, developed EVD; the woman died. The case 
patient’s sister and her husband also developed EVD and died, as did another female relative who 
lived with the case patient. Another man, and a woman and her two sons, who lived in the house 
where the baby was born, were infected; the man died. This brought a total of five deaths and four 
survivors as secondary cases.  
 Case 5 
Initial presentation and clinical course 
In May 2015 a 19-year-old female from Freetown presented at the Aberdeen Women’s Centre at 36 
weeks gestation after noting an absence of fetal movement for several days. An ultrasound 
documented fetal demise. The patient underwent induction of labour, and two skilled birth 
attendants in PPE assisted with the delivery. 
The mother was discharged home the day of delivery. As per routine procedure for all deaths, an 
oral swab was taken of the neonate. The swab tested positive for EBOV. Coincidentally, on the 
following day, the mother returned to the Centre to collect prescribed medications; she was tested 
for EBOV by RT-PCR and found to be negative. Further antibody testing of the mother indicated 
presence of IgG and negative for IgM, confirming that she was an EVD survivor with subclinical 
illness at some point prior to delivery.  
EBOV exposure  
The source of the mother’s infection could not be determined. 
Secondary cases 
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None detected. 
Case 6 
In May 2015, a 20-year old female in Port Loko district delivered a healthy newborn at 34 weeks of 
gestation. The family and birth attendants reported that prior to delivery, the patient was 
experiencing episodic abdominal pain consistent with labour, without any other symptoms. 
Four women assisted with the home-delivery, including a traditional birth attendant. All reported 
wearing gloves while providing care and post-delivery cleaning. Approximately an hour after 
delivery, the patient died unattended. There had been no post-partum hemorrhage, no observed 
maternal seizure activity or change in mental status. The placenta was not discoloured. It was 
discarded in a latrine. The family reported the death as an alert, and the burial team conducted a 
post-mortem Ebola virus oral swab for RT-PCR and safe burial of the patient. The result came back 
positive. 
The neonate became unwell at home on day 7 of life, and died on day 11. The neonate was not 
taken to an ETC for testing and care, because the household and community refused transfer. The 
neonate received a safe burial, and was diagnosed with EVD by post-mortem swab. 
EBOV exposure 
During the case investigation, it was uncovered that the patient had been in contact with her mother 
who had recently died of EVD.  
Secondary cases  
One caregiver of the neonate and two of the caregiver’s children who resided in the same 
quarantine home were infected with EBOV from exposure to the neonate. An additional caregiver 
who had exposure to both the mother and the neonate also became infected. 
DISCUSSION 
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Pregnant women require special attention during an EVD outbreak. As reported in this case series, 
the clinical presentation of EVD in pregnant women may be atypical and difficult to recognize, 
compromising appropriate care and posing a transmission risk to caregivers. Providing care for the 
neonates poses additional risks. In all instances, the neonates were incubating Ebola virus, and at 
least two were documented to be asymptomatic while viremic, and thus – infectious while 
asymptomatic. EVD in neonates was universally fatal in this series. Our findings are particularly 
timely in light of the large ongoing EVD outbreak in Democratic Republic of the Congo, in at least 115 
pregnant women with probable or confirmed EVD have been identified (EVD in DRC response team, 
preliminary data). Our findings raise three important issues about the clinical and public health 
management of pregnant women during an EVD outbreak.  
Case definition 
As these cases illustrate, pregnant women who subsequently test positive for EBOV may initially 
present in labour without fever or typical symptoms of EVD; hence, current EVD case definitions lack 
sensitivity for pregnant women. The apparent lack of typical EVD symptoms may be because the 
immunologic changes associated with pregnancy alter the manifestations of EVD; because the 
normal symptoms of pregnancy, like abdominal pain, may overshadow and mask those of EVD; 
because pregnant women may be reluctant to admit they have symptoms of EVD; or a combination 
of these factors. Importantly, only one case patient was identified at the time of presentation as 
having an epidemiologic link to a known case and was under surveillance; others might have 
concealed their history or had no known history of EVD exposure. This illustrates that the 
epidemiologic criterion for suspicion of EVD is unreliable as a means of screening, and that 
heightened IPC measures should be applied to all pregnant women presenting for obstetrical care in 
an Ebola outbreak.  
Infected newborns may also not manifest typical signs of EVD, and may even remain asymptomatic 
despite having positive blood tests for EBOV by RT-PCR (and therefore being potentially infectious). 
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These findings are consistent with the initial reports by Piot et al. of EVD in 10 infants born to 
women who died of EVDin which the infants died without recognition of a preceding illness typical of 
EVD3 (recognizing that laboratory confirmation of EVD was not available in these infants). 
In the West Africa outbreak, as in previous ones, questions about pregnancy had not been routinely 
incorporated into epidemiologic case investigation forms; this remains the case for the standard 
epidemiologic case investigation form in use in the current DRC outbreak. Given the impact of 
pregnancy on EVD, we strongly recommend that specific pregnancy-related questions be 
incorporated into EVD case investigation forms. 
Obstetric care 
In Sierra Leone, varying approaches were undertaken to mitigate the potential risk posed by 
pregnant women with EVD: staff at some facilities wore full PPE for all deliveries, regardless of EVD 
case or contact status; in a limited number of other facilities (e.g. PCMH), staff performed blood 
tests for EBOV RT-PCR on all pregnant women who arrived in labour from select high incidence 
districts. This latter approach was only feasible because of the on-site presence of rapid EBOV 
testing capability, and sufficient laboratory capacity to absorb the higher workload. It should be 
noted that staff followed contact precautions with gowns and gloves regardless of testing results. 
Garde, et al. have recently published a detailed description of the procedures undertaken at 
PCMH.29 
All health facilities which provide obstetrical care should be prepared, and receive necessary 
training, to safely care for pregnant women during an EVD outbreak using appropriate IPC 
precautions. Given the limited sensitivity of existing case definitions and laboratory tests, strict 
contact precautions should always be followed. Women who are identified as contacts and those 
who meet the EVD suspect case definition should ideally be cared for and delivered in ETCs. If 
circumstances permit, during an EVD outbreak, all deliveries should have RT-PCR testing (onsite or 
Jo
urn
l P
re-
pr
of
14 
 
offsite) of maternal blood, amniotic fluid and umbilical cord blood. Babies born to mothers with EVD 
are at very high risk and should be cared for with contact precautions and closely monitored for 21 
days. Our recommendations are consistent with recently issued WHO guidelines for the 
management of pregnant and breastfeeding women in the context of Ebola virus disease.30 
Pregnant contacts  
From March 2015, in Port Loko district, all willing asymptomatic pregnant women from quarantined 
homes were admitted for observation at maternity Holding Centres such as PCMH for the duration 
of their 21-day monitoring period as EVD contacts. This approach was based on several tenets: 1) 
that appropriate antenatal care (ANC) was not possible while in quarantine; 2) that a pregnant 
contact who miscarried or went into labour while in a quarantined home would have difficulty 
obtaining timely and safe medical care and could expose household members to large amounts of 
potentially infectious bodily fluids; and 3) routine health services often refused to care for pregnant 
women in labour or with vaginal bleeding during the Ebola outbreak.  
This precautionary approach was not without challenges, including convincing asymptomatic women 
to be admitted and relatively isolated from others in an EVD facility. While maternity waiting homes 
next to district hospitals previously existed as an accepted strategy for ensuring timely access to 
clinic-based obstetrical case in rural areas of Sierra Leone, the widespread quarantines imposed 
during the West Africa outbreak had a decidedly negative impact on this approach. A Médecins Sans 
Frontières survey of eight pregnant women found that “women do not want to come to an ETC for 
*antenatal care+ and delivery” *unpublished data+. Admitting asymptomatic and potentially 
uninfected women into an EVD isolation facility along with confirmed EVD cases could result in 
nosocomial spread, with risks to the individual as well as public trust. These risks could be mitigated 
by creating specialized maternity care sections in ETCs designated for antenatal care of 
asymptomatic pregnant women.  
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In late April of 2015, national policy was developed to harmonize the approaches discussed above. 
An agreement was reached to enumerate all pregnant women identified as contacts of EVD cases. 
Rather than transporting these pregnant women to other facilities for antenatal care, it was decided 
that they would remain under quarantine and mobile medical teams would provide antenatal care 
through individual home visits. For example, in Port Loko, a Mother and Baby Unit was established 
by the non-governmental organization GOAL for all pregnant women in quarantined homes. If such 
women required any care within their 21 days, including uncomplicated deliveries, they were 
transferred to the unit for treatment. 
 
CONCLUSION 
 
The large numbers of cases in the West Africa EVD outbreak provided an unprecedented opportunity 
for observations of EBOV transmission and the clinical course of EVD illness and recovery. Our cases 
add to the sparse literature focusing on pregnant women in this context, highlighting several 
challenges and implications for outbreak control.  
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Table 1: Clinical course and epidemiologic features of pregnant women with atypical Ebola virus disease 
Case  District of 
residence  
Month/ 
year  
At presentation  Clinical outcomes  EBOV 
exposure 
history  
Public 
health 
outcomes 
(2° cases)  
Age Stage 
of 
preg-
nancy  
Symp-
toms & 
signs  
Met 
EVD 
case 
defn.  
Fetal/ 
preg-
nancy 
outcome 
Reason for 
suspicion of 
EVD  
Maternal 
outcome 
Maternal 
EBOV test 
result  
Neonatal 
outcome 
Neonate 
EBOV test 
result  
1.  Bombali  Nov 2014  25yrs  T3  Labor 
pains  
No  Live birth 
by SVD in 
MGH  
PPH at 1 day 
post-
delivery (still 
afebrile)  
Died at 1 
day post-
delivery 
p-m oral 
swab 
EBOV (+)  
discharged 
to family;  
died  
Not done Hx of QH, 
gave false 
address at 
presentata
ion.  
1 other 
patient 
infected by 
the mother;  
unknown 
number of 
family 
members 
infected by 
the newborn   Jo
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2.  Port Loko  Dec 2014  18yrs  T3  Labor 
pains, V, 
D, H, 
muscle 
pain; 
afebrile 
initially 
but T° 
during 
labor 
No 
(susp
ected 
by 
clinic
al 
judge
ment)  
Live birth 
by SVD at 
PCMH EVD 
Isolation 
Unit  
Based on 
symptoms  
PPH 
post-
delivery, 
died  
Blood 
EBOV (+)  
Became 
symptom-
atic at day 
15, died 
day 19  
Blood 
EBOV (+)  
Unknown None 
3.  Kambia  Jan 2015  35yrs  T3 Labor 
pains  
No  Live birth 
by SVD at 
PCMH  
Nil at time of 
delivery  
Discharg
ed home 
post-
delivery; 
became 
febrile 
unknown 
days 
Blood 
EBOV –ve x 
2 at time 
of delivery; 
p-m oral 
swab 
EBOV (+)  
Became 
unwell at 
unknown 
day of life, 
died next 
day 
p-m oral 
swab EBOV 
(+) 
In QH at 
time of 
delivery  
23 (1 family 
member, 
resulting in 
17 
confirmed & 
5 suspect 
cases)  Jo
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l P
re-
pro
of
23 
 
later; 
died in 
RTA   
4.  Port Loko  Feb 2015  38yrs  T3  Labor 
pains  
No  Live birth 
by SVD at 
home  
PPH few hrs 
post-
delivery  
Died on 
day of 
delivery  
p-m oral 
swab 
EBOV (+)  
Became 
unwell at 
day 7, died 
day 8  
EBOV –ve 
at 3 days 
old, (+) at 
5 days old  
Visited QH 
of family 
member  
9 household 
contacts (5 
died; 4 
survived)  
5.  Freetown May 
2015 
19yrs T3 Fetal 
death 
No Induced 
delivery of 
stillborn in 
hospital 
None at 
time of 
delivery 
Discharg
ed home 
asympto
matic 
EBOV –ve 
from blood 
sample 
Stillborn EBOV (+) 
from oral 
swab 
None 
identified 
None 
identified 
6.  Port Loko May 
2015 
20yrs T3 Labor 
pains 
No Live birth 
by SVD at 
home  
None at 
time of 
delivery 
Died on 
day of 
delivery 
p-m oral 
swab 
EBOV (+) 
Became 
unwell at 
day 7, died 
EBOV (+) 
from oral 
swab 
Patient’s 
mother 
had EVD 
4 (2 
caregivers, 2 
children) 
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day 11 
AP= abdominal pain; D= diarrhoea; EVD = Ebola virus disease; EBOV = Ebola virus; HCW: healthcare worker; H= headache; MGH= Makeni General Hospital (Bombali); p-m= post-mortem; 
PCMH= Princess Christian Maternity Hospital (Freetown); PHU= peripheral health unit; PPH = post-partum hemorrhage; PV= per vagina; QH = quarantined home; RTA= road traffic 
accident; SVD = spontaneous vaginal delivery; T°= temperature; T= trimester of pregnancy; V= vomiting; (+) = positive 
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 Pregnant women infected with Ebola virus may present atypically 
 Current Ebola virus disease case definitions are inappropriate for pregnant women 
 Infected newborns may appear asymptomatic despite being potentially infectious 
 Obstetric care during an Ebola outbreak requires heightened precautions 
 Pregnant contacts of Ebola-infected individuals require special considerations  
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